Inventor · disambiguated record
Roland Neuhaus
Also filed as: NEUHAUS ROLAND
25 granted patents·19 pending applications·75 citations·filing 1996–2022
93Inventor score
Top patents by PatentIndex Score
44 records- 0190US8987273B2Substituted imidazo[1,2-B]pyridazinesREHWINKEL HARTMUT·Filed 2011·Granted Mar 24, 2015·28 cites·18 claims
- 0288US9957235B2Benzimidazol-2-amines as mIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted May 1, 2018·8 cites·34 claims
- 0386US10179123B22-aryl- and 2-arylalkyl-benzimidazoles as mIDH1 inhibitorsBayer Pharma AG·Filed 2016·Granted Jan 15, 2019·4 cites·15 claims
- 0486US9951027B2Benzimidazol-2-amines as MIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted Apr 24, 2018·8 cites·22 claims
- 0585US10138226B2Benzimidazol-2-amines as MIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted Nov 27, 2018·6 cites·29 claims
- 0682US9388140B2Substituted benzimidazolesKLAR ULRICH·Filed 2012·Granted Jul 12, 2016·3 cites·18 claims
- 0779US10137110B21-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumorsBayer Pharma AG·Filed 2015·Granted Nov 27, 2018·4 cites·29 claims
- 0873US8993630B2Substituted sulphonamido phenoxybenzamidesHARTUNG INGO·Filed 2009·Granted Mar 31, 2015·2 cites·11 claims
- 0973US8975265B2Substituted imidazo[1,2-a]pyrimidines and —pyridinesINCE STUART·Filed 2011·Granted Mar 10, 2015·3 cites·10 claims
- 1072US9370517B2Substituted pyrazolopyrimidines as Akt kinase inhibitorsBAYER IP GMBH·Filed 2013·Granted Jun 21, 2016·2 cites·8 claims
- 1169US10414734B25-hydroxyalkylbenzimidazoles as mIDH1 inhibitorsBayer Pharma AG·Filed 2016·Granted Sep 17, 2019·1 cites·16 claims
- 1269US2022241261A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2021·Application pending·0 cites
- 1368US11427578B1Substituted pyrrolopyridine-derivativesBayer Pharma AG·Filed 2018·Granted Aug 30, 2022·1 cites·18 claims
- 1467US9206185B2Imidazopyridazines as Akt kinase inhibitorsBärfacker Lars·Filed 2012·Granted Dec 8, 2015·2 cites·39 claims
- 1567US2019388410A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2019·Application pending·0 cites
- 1660US2024287048A1Substituted acyl sulfonamides for treating cancerBROAD INST INC·Filed 2021·Application pending·0 cites
- 1757US2018289685A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2016·Application pending·0 cites
- 1854US2024174683A1Map4k1 inhibitorsBAYER AG·Filed 2022·Application pending·0 cites
- 1951US10442772B2Benzimidazol-2-amines as mIDH1 inhibitorsBayer Pharma AG·Filed 2018·Granted Oct 15, 2019·0 cites·21 claims
- 2051US9512130B2Substituted imidazopyridazinesBayer Pharma AG·Filed 2014·Granted Dec 6, 2016·0 cites·10 claims
- 2151US2024279207A1Substituted acyl sulfonamides for treating cancerBROAD INST INC·Filed 2021·Application pending·0 cites
- 2248US2022411381A1Pyrimidinedione derivativesBAYER AG·Filed 2020·Application pending·0 cites
- 2347US6946466B2Aromatic sulfonamides as peroxynitrite-rearrangement catalystsSCHERING AG·Filed 2003·Granted Sep 20, 2005·0 cites·23 claims
- 2446US2004127479A1Peroxynitrite rearrangement catalystsMERCK PATENT GMBH·Filed 2003·Application pending·0 cites
- 2545US2003045541A1GABA-Receptor modulators with NMDA-Antagonistic activityFiled 2002·Application pending·0 cites
- 2644US9512126B2Substituted imidazopyridazinesBAYER IP GMBH·Filed 2013·Granted Dec 6, 2016·0 cites·16 claims
- 2744US8987286B2Substituted pyrimido[1,2-b]indazoles and their use as modulators of the Pi3K/Akt pathwayREHWINKEL HARTMUT·Filed 2011·Granted Mar 24, 2015·0 cites·11 claims
- 2844US2017037028A1Glucose transport inhibitorsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2943US12357603B2Acyl sulfonamides for treating cancerBAYER AG·Filed 2020·Granted Jul 15, 2025·0 cites·17 claims
- 3043US9604989B2Imidazopyridazines as Akt kinase inhibitorsBAYER IP GMBH·Filed 2015·Granted Mar 28, 2017·0 cites·6 claims
- 3143US2005288324A1Aromatic sulfonamides as peroxynitrite-rearrangement catalystsBLUME THORSTEN·Filed 2005·Application pending·0 cites
- 3242US9260435B2Substituted imidazopyrazines as Akt kinase inhibitorsBAYER IP GMBH·Filed 2013·Granted Feb 16, 2016·0 cites·8 claims
- 3342US2016009725A1Pyrrolo- and pyrazolo-triazolodiazepines as bet-protein inhibitors for treating hyperproliferative diseasesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3442US2015376196A14-substituted pyrrolo- and pyrazolo-diazepinesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3540US11319324B2Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitorsBAYER AG·Filed 2018·Granted May 3, 2022·0 cites·11 claims
- 3640US2022047603A1Substituted pyrrolopyridine-derivativesBAYER AG·Filed 2019·Application pending·0 cites
- 3739US10919862B2Fused imidazoles as mIDH1 inhibitorsBayer Pharma AG·Filed 2016·Granted Feb 16, 2021·0 cites·25 claims
- 3839US9663523B2BET protein-inhibiting 5-aryltriazoleazepinesBayer Pharma AG·Filed 2013·Granted May 30, 2017·0 cites·10 claims
- 3938US2014255392A1Substituted imidazopyridines and intermediates thereofKOPPITZ MARCUS·Filed 2012·Application pending·0 cites
- 4033US6136805AQuinoxaline dione derivatives, their production and their use in medicamentsSCNERING AG·Filed 1996·Granted Oct 24, 2000·3 cites·8 claims
- 4132US2012263714A1Substituted halophenoxybenzamide derivativesHITCHCOCK MARION·Filed 2010·Application pending·0 cites
- 4232US2017210738A1Glucose transport inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 4332US2017226081A1Glucose transport inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 4431US2013184273A1Bicyclic pyrimidinesINCE STUART·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roland Neuhaus files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →